Table 1

Factors associated with persistent proteinuria among HIV-infected, ART naïve children, 2–12 years old (n=220)
Variable Persistent proteinuria n (%) OR 95% CI P value
Median age in months (Q1;Q3) 106 (86;121) 1.01 0.99-1.04 0.175
Gender  males 6 (5.9) 0.69 0.21-2.35 0.557
     females 5 (4.2)
WAZ  ≥−2 3 (4.1) 3.36 0.82-13.63 0.09
     <−2 8 (12.5)
WHZ  ≥−2 7 (3.6) 7.96 1.71-35.87 0.0005
     <−2 4 (22.2)
eGFR(ml/min/1.73m2)
     ≥90 7 (4.9) 1.09 0.31-3.84 0.897
     <90 4 (5.3)
Diastolic BP  normal 10 (5.2) 1.4 0.17-11.80 0.757
     high 1 (7.1)
Clinical stages 1&2 1 (1.0) 9.17 1.15-72.96 0.036
Clinical stages 3&4 10 (8.4)
Immunological stages
Not significant 3 (3.7) - - -
Mild 2 (5.7) 1.60 0.25-10.0 0.618
Advanced 3 (8.6) 2.47 0.47-12.88 0.284
Severe 3 (6.5) 1.84 0.36-9.50 0.468

WAZ- Weight-for-age z-score.

WHZ- Height-for-age z-score.

Logistic regression and odds ratios.

Dondo et al.

Dondo et al. BMC Pediatrics 2013 13:75   doi:10.1186/1471-2431-13-75

Open Data